Try a new search

Format these results:

Searched for:

person:gruccf01

in-biosketch:true

Total Results:

1


A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder

Breitborde, Nicholas Jk; Dawson, Spencer C; Woolverton, Cindy; Dawley, David; Bell, Emily K; Norman, Kaila; Polsinelli, Angelina; Bernstein, Beth; Mirsky, Pamela; Pletkova, Christine; Grucci, Felix; Montoya, Carly; Nanadiego, Bernard; Sarabi, Ehsan; DePalma, Michael; Moreno, Francisco
BACKGROUND:Cognitive remediation (CR) has shown significant promise in addressing the cognitive deficits that accompany serious mental illness. However, this intervention does not appear to completely ameliorate the cognitive deficits that accompany these illnesses. D-cycloserine (DCS), an NMDA receptor partial agonist, has been shown to enhance the therapeutic benefits of learning-based psychosocial interventions for psychiatric disorders. Thus, the goal of this study is to examine the utility of combining cognitive remediation and d-cycloserine in the treatment of cognitive deficits among individuals with bipolar disorder. METHODS/DESIGN/METHODS:Approximately forty individuals with bipolar disorder will be recruited to participate in this study. Participants will be randomized to one of two study arms: CR + DCS or CR + placebo. The primary outcome for this study is change in cognitive functioning. We will also examine several secondary outcomes, including the rate of change of cognitive functioning, social functioning, and symptomatology. DISCUSSION/CONCLUSIONS:Cognitive deficits are a rate-limiting factor in functional recovery among individuals with bipolar disorder. Unfortunately, treatment options for these deficits are limited. The results of the proposed study may reveal a valuable intervention strategy (i.e., CR with concurrent DCS) to improve cognitive functioning among individuals with bipolar disorder. Ultimately, this treatment strategy may prove useful in addressing the cognitive deficits that are ubiquitous across serious mental illnesses. TRIAL REGISTRATION/BACKGROUND:ClinicalTrials.gov NCT01934972.
PMCID:4270034
PMID: 25566387
ISSN: 2050-7283
CID: 5344952